Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RX-af01 / Sun Yat-sen University
NCT05576961: Safety and Efficacy of RX-af01 Combined With PD-1 Antibody	Recruiting	1/2	60	RoW	RX-af01, Toripalimab, Mixed bacteria, High dose RX-af01	Sun Yat-sen University	Solid Tumor, Immune Checkpoint Inhibitor, Intestinal Flora	12/24	12/24